Home » Newsletters » BioWorld Science

BioWorld Science

June 11, 2007

View Archived Issues

New treatment options for inflammatory disorders disclosed in recent patents

New therapeutic agents for metabolic disorders reported in recent patents

Tetrathiomolybdate well tolerated in idiopathic pulmonary fibrosis

Quadrivalent papillomavirus vaccine prevents vulvar and vaginal lesions

New ghrelin receptor ligands show antiobesity properties by increasing energy expenditure

CUV-1647 begins phase III trial in erythropoietic protoporphyria

GlaxoSmithKline and Biovitrum terminate program in obesity

Phosphagenics awarded AusIndustry grant for TPM-02

Iomai updates development of adjuvant patch

APT in-licenses inhalable form of ciclosporin for lung transplant rejection

Abbott and Caprion extend discovery partnership in oncology

Androxal shows significant positive effects in men with secondary hypogonadism

Studies comparing zolpidem oral spray to Ambien meet objectives

New therapeutic option for glaucoma reported in recent Solvay patent

ROX-888 provides effective pain relief following major abdominal surgery

Fujirebio receives new patent for HE4 biomarker with utility in ovarian cancer

Genomic Health reports new data for Oncotype DX breast cancer assay

Novel Ras inhibitor has promising activity and safety in hematological malignancies

Encouraging phase I results obtained for sapacitabine in hematological cancers

Data presented at ASCO for AEZS-108, a targeted cytotoxic-LHRH conjugate

Interim analysis of phase II clinical trials on XL-999

TroVax alone or combined with IL-2 or interferon effective and safe in renal cell carcinoma

Indibulin capsule formulation well tolerated and potentially active in solid tumor patients

Atacicept associated with stable disease at well-tolerated doses in B-CLL

Novel LFA-1/ICAM-1 interaction inhibitors claimed in recent patent

Avastin launched in Japan for colorectal cancer

BLA submission completed for IL-Trap in CAPS

Arixtra launched in Japan

Japanese launch for Adoair

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...